Full Press Release Details
SAN FRANCISCO, Calif., July 31, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, plans to report results for the second quarter ended June 30, 2018, on Thursday, August 9, 2018, after NASDAQ market close.
UNITY will not conduct a conference call in conjunction with the financial results press release.
About UNITY Biotechnology